Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06578169
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-13
Brief Title:
Initiation of Exogenous Female Sex Hormones and Airway Responsiveness to Methacholine - A Prospective Cohort Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Initiation of Exogenous Female Sex Hormones and Airway Responsiveness to Methacholine - A Prospective Cohort Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The project aims to investigate the effect of female sex hormone treatment both contraceptive treatment and hormone therapy during menopause on bronchial hyperreactivity in adult women The study is a prospective cohort study involving 300 women examining airway responsiveness before and after the initiation of hormone treatment whether as hormone therapy in menopause or contraceptive treatment Participants will be recruited from general practitioners in the Capital Region of Denmark Lung function bronchial hyperreactivity airway inflammation and body composition will be assessed before and after hormone treatment Blood samples will also be collected and stored for later analysis of inflammation markers The study will include women aged 18 to 75 who are about to begin hormone treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None